News
Cohesin is a protein that forms a ring-shaped complex which wraps and alters the DNA molecule shape. It moves through the DNA ...
The NLP in Healthcare & Life Sciences Market is expected to significantly increase in size from USD 5.18 billion in 2025 to USD 16.01 billion ...
The NLP in Healthcare & Life Sciences Market is expected to significantly increase in size from USD 5.18 billion in 2025 to USD 16.01 billion by 2030, growing at a CAGR of 25.3% during the forecast ...
Part 2 of a two-part commentary on Georgia’s tort reform legislation (SB 68) summarizes some of the major changes under that ...
The answers to some of medicine's biggest challenges are hiding in the rarest of diseases. A new podcast from Pacific ...
EpiVax, Inc., a leader in preclinical immunogenicity assessment for biologic therapeutics and vaccines, is pleased to ...
Alamar Biosciences, a company powering precision proteomics to enable the earliest detection of disease is proud to announce a strategic collaboration with SciLifeLab to advance translational ...
EBC-129 is the first made-in-Singapore antibody-drug conjugate (ADC) to enter clinical development. It selectively targets a tumour-specific N-glycosylated epitope on both CEACAM5 and CEACAM6.
Scientists discover unique insulin responses in each person, opening new paths for early diabetes detection and treatment.
Part 1 of a two-part commentary on Georgia’s tort reform legislation (SB 68) summarizes some of the major changes under that ...
Samsung's venture arm is looking to invest in California-based medical device startup Exo, Bloomberg reported.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results